Ablynx, 3.25% 27may2020, EUR (Conv.) (FIGI BBG008TGVZH5, BE6278650344, WKN A1Z186)
国内債券, 転換社債, Senior Unsecured
国内債券, 転換社債, Senior Unsecured
|
Ablynx is a Belgian biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. Today, the Company has more than 30 proprietary and partnered programmes in development in various therapeutic ...
Ablynx is a Belgian biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. Today, the Company has more than 30 proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, immuno-oncology, oncology and respiratory disease.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡